Clinical Trial

Safety and Efficacy of L. Lactis CKDB001 in Subjects With Early Alzheimer's Disease

Name: Safety and Efficacy of L. Lactis CKDB001 in Subjects With Early Alzheimer's Disease — clinical trial record (NCT07496021)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

Randomized, Placebo-Controlled, Double-Blind, 24-Week Proof-of-Concept Study to Evaluate the Safety and Efficacy of L. Lactis CKDB001 in Subjects With Early Alzheimer's Disease

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-03-22.

Trial Details

NCT Number	NCT07496021
Lead Sponsor	CKD Bio Corporation
Conditions	Early Alzheimers Disease
Enrollment	60 participants
Start Date	2026-02-23
Primary Completion	2027-05-31 (estimated)
Study Completion	2027-05-31 (estimated)
Updated on ClinicalTrials.gov	2026-03-30